SpeeDx Supports Papua New Guinea with COVID-19 Tests

Provision of SARS-CoV-2 tests reinforces PNG sovereign capacity to respond to ongoing pandemic.

SpeeDx announce they have donated PlexPCR^® SARS-CoV-2 tests and PlexPrime^® SARS-CoV-2 Genotyping reagents to support Papua New Guinea (PNG) in their response to the ongoing COVID-19 pandemic.

SpeeDx have a long-held relationship with the Kirby Institute, a world-leading health research institute at UNSW Sydney. The Kirby Institute is dedicated to eliminating infectious diseases, globally, and for more than two decades have worked in close collaboration and partnership with the PNG Institute of Medical Research (PNGIMR), national and provincial health authorities, development agencies, and communities in Papua New Guinea.

The PNGIMR was established in 1968 to conduct health and medical research into diseases affecting Papua New Guineans. Already deeply engaged in world-leading research on malaria, pneumonia, filariasis, respiratory disease, sexual and reproductive health, the PNGIMR has pivoted to swiftly take on a key role in the national COVID-19 response in the country.

Read Press Release